Headline News about 4D Molecular Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for 4D Molecular Therapeutics
July 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_9302.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for 4D Molecular Therapeutics
June 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/08/oxford_industries_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/08/fdmt.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/08/carvana_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/08/semtech_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/05/12/coinbase_global_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for 4D Molecular Therapeutics
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for 4D Molecular Therapeutics
March 16, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/fdmt.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/netgear_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for 4D Molecular Therapeutics
January 30, 2023
Via Benzinga
Expert Ratings for 4D Molecular Therapeutics
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/image20.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/fdmt_logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/30/fdmt_logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23618.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710004/biotech-laboratory-at-work-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22686.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/image-american_eagle_outfitters.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.